<--- Back to Details
First PageDocument Content
Health / Copayment / Formulary / Generic drug / Medical prescription / Pharmaceutical drug / Medicare Part D / Prescription costs / Pharmacology / Pharmaceutical sciences / Pharmaceuticals policy
Date: 2014-03-28 12:48:12
Health
Copayment
Formulary
Generic drug
Medical prescription
Pharmaceutical drug
Medicare Part D
Prescription costs
Pharmacology
Pharmaceutical sciences
Pharmaceuticals policy

Effective[removed]Preferred Product Formulary By Therapeutic Class Restat administers your prescription benefit plan. Our goal is to provide the highest quality pharmaceutical care, at lower costs. The most effec

Add to Reading List

Source URL: www.restat.com

Download Document from Source Website

File Size: 1,51 MB

Share Document on Facebook

Similar Documents

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

DocID: 1xTu9 - View Document

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

DocID: 1tPLN - View Document

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

DocID: 1ttzb - View Document

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

DocID: 1th0B - View Document

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

DocID: 1sahA - View Document